Lion Point Capital, LP - Q4 2019 holdings

$1.08 Billion is the total value of Lion Point Capital, LP's 26 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 38.5% .

 Value Shares↓ Weighting
IWM BuyISHARES TRput$362,817,000
+82.9%
2,190,000
+67.1%
33.70%
+52.4%
CSIQ BuyCANADIAN SOLAR INC$96,990,000
+31.7%
4,388,709
+12.6%
9.01%
+9.7%
DRRX  DURECT CORP$71,250,000
+106.5%
18,750,0000.0%6.62%
+72.0%
LSCC SellLATTICE SEMICONDUCTOR CORP$69,539,000
+2.0%
3,633,188
-2.6%
6.46%
-15.1%
MDCO  MEDICINES CO$66,588,000
+69.9%
783,9500.0%6.18%
+41.5%
XOP SellSPDR SERIES TRUSTput$63,765,000
-29.7%
2,690,500
-33.6%
5.92%
-41.4%
ACHC SellACADIA HEALTHCARE COMPANY IN$44,796,000
-12.6%
1,348,472
-18.2%
4.16%
-27.2%
CPE NewCALLON PETE CO DEL$39,619,0008,202,705
+100.0%
3.68%
IWM NewISHARES TRrussell 2000 etf$36,613,000221,000
+100.0%
3.40%
AA BuyALCOA CORP$36,506,000
+11.3%
1,697,182
+3.8%
3.39%
-7.3%
SPY NewSPDR S&P 500 ETF TRtr unit$33,455,000103,945
+100.0%
3.11%
PDCE  PDC ENERGY INC$30,368,000
-5.7%
1,160,4500.0%2.82%
-21.5%
PRSP  PERSPECTA INC$23,796,000
+1.2%
900,0000.0%2.21%
-15.7%
L100PS SellARCONIC INC$20,769,000
-40.8%
675,000
-50.0%
1.93%
-50.7%
LBTYA  LIBERTY GLOBAL PLC$18,192,000
-8.1%
800,0000.0%1.69%
-23.5%
MRNS BuyMARINUS PHARMACEUTICALS INC$13,769,000
+159.1%
6,374,740
+84.7%
1.28%
+115.7%
SCOR  COMSCORE INC$9,495,000
+158.6%
1,922,2410.0%0.88%
+115.6%
EQT  EQT CORP$8,768,000
+2.4%
804,4500.0%0.81%
-14.7%
NLNK NewNEWLINK GENETICS CORP$7,880,0003,114,733
+100.0%
0.73%
XOP NewSPDR SERIES TRUSTs&p oilgas exp$6,871,000289,915
+100.0%
0.64%
EXTR  EXTREME NETWORKS INC$5,983,000
+1.3%
811,8350.0%0.56%
-15.6%
LOGC  LOGICBIO THERAPEUTICS INC$3,600,000
-33.4%
500,0000.0%0.33%
-44.6%
ECA  ENCANA CORP$2,113,000
+2.0%
450,5440.0%0.20%
-15.2%
XEC  CIMAREX ENERGY CO$1,845,000
+9.5%
35,1620.0%0.17%
-9.0%
OPESU  OPES ACQUISITION CORPunit 03/07/2023$876,000
+0.6%
83,4380.0%0.08%
-16.5%
SRCI  SRC ENERGY INC$473,000
-11.6%
115,0040.0%0.04%
-26.7%
ExitMEDICINES COnote 2.750% 7/1$0-5,000,000
-100.0%
-0.67%
ALDR ExitALDER BIOPHARMACEUTICALS INC$0-1,204,600
-100.0%
-2.53%
FSLR ExitFIRST SOLAR INC$0-611,933
-100.0%
-3.96%
CRZO ExitCARRIZO OIL & GAS INC$0-4,674,400
-100.0%
-4.48%
ExitALDER BIOPHARMACEUTICALS INCnote 2.500% 2/0$0-53,517,000
-100.0%
-6.61%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CANADIAN SOLAR INC21Q2 202125.6%
ALCOA CORP21Q1 20228.0%
ISHARES TR19Q3 202339.2%
COMSCORE INC19Q4 20225.8%
HALCON RES CORP15Q3 20233.3%
KINIKSA PHARMACEUTICALS LTD15Q3 20233.1%
LUMOS PHARMA INC15Q3 20232.8%
DURECT CORP14Q3 202210.5%
ARCONIC INC14Q1 20204.4%
MARINUS PHARMACEUTICALS INC13Q3 202311.6%

View Lion Point Capital, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Lion Point Capital, LP Q4 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SIERRA WIRELESS INCJune 07, 20221,810,6714.7%
BATTALION OIL CORPFebruary 14, 2022352,8512.2%
DURECT CORPFebruary 14, 202215,486,0046.8%
LUMOS PHARMA, INC.February 12, 2021407,1924.9%
BurgerFi International, Inc.January 11, 20212,745,93815.7%
Canadian Solar Inc.November 27, 20202,453,7244.1%
NEWLINK GENETICS CORPFebruary 14, 20203,114,7338.3%
CARRIZO OIL & GAS INCOctober 29, 20194,584,4005.0%
LATTICE SEMICONDUCTOR CORPJuly 22, 20196,467,0354.9%
Cimarex Resolute LLCMarch 05, 2019? ?

View Lion Point Capital, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14
13F-HR2022-11-14

View Lion Point Capital, LP's complete filings history.

Compare quarters

Export Lion Point Capital, LP's holdings